1. NIH Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer . JAMA.1990;264: 1444-1450 .
2.
2. Fisher B , Wolmark N , Rockette H , et al.Prospective adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocal R-01 . J Natl Cancer Inst.1988;80(1): 21-29 .
3.
3. O'Connell M.A phase III trial of 5-fluorouracil and leucovorin in the treatment of advanced colorectal cancer: a Mayo Clinic/North Central Group study . Cancer.1989;63: 1026-1030 .
4.
4. Gastrointestinal Tumor Study Group . Prolongation of the disease-free interval in surgically treated rectal carcinoma . N Engl J Med.1985;312: 1465-1472 .
5.
5. Moore HCF , Haller DG.Adjuvant therapy of colon cancer . Semin Oncol.1999;26: 545-555 .
6.
6. Saltz L , Cox J , Blanke C , et al.Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer . N Engl J Med.2000;343: 905-914 .
7.
7. DeGramont A , Figer A , Seymour M , et al.Leucovorin and fluorouracil with or without oxaliplatin as first line treatment in advanced colorectal cancer . J Clin Oncol.2000;18: 2938-2947 .
8.
8. Kemeny N , Ron I.Hepatic arterial chemotherapy in metastatic colorectal patients . Semin Oncol.1999;26: 524-535 .
9.
9. VanCutsem E , Twelves C , Cassidy J , et al.Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study . J Clin Oncol.2001;19: 4097-4106 .